These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4732569)

  • 1. Intraventricular injections of L-dopa: the effect on rat locomotor activity and body temperature.
    Reichenberg K; Vetulani J
    Eur J Pharmacol; 1973 Jun; 22(3):376-9. PubMed ID: 4732569
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 3. The hypothermic effect of L-dopa in the rat.
    Maj J; Pawlowksi L
    Life Sci; 1973 Jul; 13(2):141-9. PubMed ID: 4270866
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression.
    Männistö PT; Lang A; Rauhala P; Vasar E
    Eur J Pharmacol; 1995 Feb; 274(1-3):229-33. PubMed ID: 7768276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the pharmacological action of 3,4-dihydroxy-L-phenylalanine(L-dopa) and reduction of dopa decarboxylase activity in rat liver after chronic treatment with L-dopa.
    Tanaka M; Oshima T; Hayashi S; Ishibashi C; Kobayashi S
    Eur J Pharmacol; 1973 Jun; 22(3):360-2. PubMed ID: 4732567
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 7. [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].
    Constantinidis J; Bartholini G; Geissbühler F; Tissot R
    Experientia; 1970 Apr; 26(4):381-3. PubMed ID: 5439606
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of stimulating Deiters' nucleus and medial longitudinal fasciculus on the timing of the fictive locomotor rhythm induced in cats by DOPA.
    Russell DF; Zajac FE
    Brain Res; 1979 Nov; 177(3):588-92. PubMed ID: 497853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Involvement of biogenic amines on the analgesic and central nervous system depressant action of mefenamic acid (author's transl)].
    Paeile C; Marchán E
    Arch Biol Med Exp; 1973 Dec; 9(1,2,3):52-4. PubMed ID: 4802248
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of intraventricularly administered noradrenaline and dopamine on the body temperature of the rat.
    Przewlocka B; Kaluza J
    Pol J Pharmacol Pharm; 1973; 25(4):345-55. PubMed ID: 4774243
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of acute administration of L-dopa on body temperature in man.
    Boyd AE; Mager M; Angoff G; Lebovitz HE
    J Appl Physiol; 1974 Nov; 37(5):675-8. PubMed ID: 4436192
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of serotonin synthesis by dopa and other catechols.
    Goldstein M; Frenkel R
    Nat New Biol; 1971 Oct; 233(40):179-80. PubMed ID: 5287086
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of L-dopa and (+)-amphetamine on the locomotor activity after pimozide and phenoxybenzamine.
    Maj J; Sowinska H; Kapturkiewicz Z; Sarnak J
    J Pharm Pharmacol; 1972 May; 24(5):412-4. PubMed ID: 4403816
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of catechol-O-methyl transferase by catechols and polyphenols.
    Baldessarini RJ; Greiner E
    Biochem Pharmacol; 1973 Jan; 22(2):247-56. PubMed ID: 4763253
    [No Abstract]   [Full Text] [Related]  

  • 15. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
    Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
    Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 18. L-DOPA-chlorpromazine antagonism on running activity in mice.
    Derkach P; Larochelle L; Bieger D; Hornykiewicz O
    Can J Physiol Pharmacol; 1974 Feb; 52(1):114-8. PubMed ID: 4825682
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the "late reflex discharge" and locomotor movements in acute spinal cats and rabbits treated with DOPA.
    Viala D; Valin A; Buser P
    Arch Ital Biol; 1974 Dec; 112(4):299-306. PubMed ID: 4458616
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative histochemical studies of formaldehyde-induced parenchymal fluorescence following L-DOPA administration.
    Dowson JH; Laszlo I
    J Neurochem; 1971 Dec; 18(12):2501-8. PubMed ID: 5135908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.